Cargando…

The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council

Detalles Bibliográficos
Autores principales: Wright, Abigail C, Beaudoin, Francesca L, McQueen, R. Brett, Yeung, Kai, Moradi, Ashton, Herron-Smith, Serina, Gutierrez, Eric, Lin, Grace A, Pearson, Steven D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387909/
https://www.ncbi.nlm.nih.gov/pubmed/37276043
http://dx.doi.org/10.18553/jmcp.2023.29.6.692
_version_ 1785081988856676352
author Wright, Abigail C
Beaudoin, Francesca L
McQueen, R. Brett
Yeung, Kai
Moradi, Ashton
Herron-Smith, Serina
Gutierrez, Eric
Lin, Grace A
Pearson, Steven D
author_facet Wright, Abigail C
Beaudoin, Francesca L
McQueen, R. Brett
Yeung, Kai
Moradi, Ashton
Herron-Smith, Serina
Gutierrez, Eric
Lin, Grace A
Pearson, Steven D
author_sort Wright, Abigail C
collection PubMed
description
format Online
Article
Text
id pubmed-10387909
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103879092023-07-31 The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council Wright, Abigail C Beaudoin, Francesca L McQueen, R. Brett Yeung, Kai Moradi, Ashton Herron-Smith, Serina Gutierrez, Eric Lin, Grace A Pearson, Steven D J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2023-06 /pmc/articles/PMC10387909/ /pubmed/37276043 http://dx.doi.org/10.18553/jmcp.2023.29.6.692 Text en Copyright © 2023, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Perspectives on Value
Wright, Abigail C
Beaudoin, Francesca L
McQueen, R. Brett
Yeung, Kai
Moradi, Ashton
Herron-Smith, Serina
Gutierrez, Eric
Lin, Grace A
Pearson, Steven D
The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council
title The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council
title_full The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council
title_fullStr The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council
title_full_unstemmed The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council
title_short The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council
title_sort effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: a summary from the institute for clinical and economic review’s midwest public advisory council
topic Perspectives on Value
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387909/
https://www.ncbi.nlm.nih.gov/pubmed/37276043
http://dx.doi.org/10.18553/jmcp.2023.29.6.692
work_keys_str_mv AT wrightabigailc theeffectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT beaudoinfrancescal theeffectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT mcqueenrbrett theeffectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT yeungkai theeffectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT moradiashton theeffectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT herronsmithserina theeffectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT gutierrezeric theeffectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT lingracea theeffectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT pearsonstevend theeffectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT wrightabigailc effectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT beaudoinfrancescal effectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT mcqueenrbrett effectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT yeungkai effectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT moradiashton effectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT herronsmithserina effectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT gutierrezeric effectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT lingracea effectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil
AT pearsonstevend effectivenessandvalueoffezolinetantformoderatetoseverevasomotorsymptomsassociatedwithmenopauseasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestpublicadvisorycouncil